Skip to main content
Premium Trial:

Request an Annual Quote

BioInform s Licensing Roundup: Jun 6, 2005

Premium
BioInform's Licensing Roundup: May's Software, Database, and IT Deals
Company Product Licensees
Software Genedata Screener NIH Chemical Genomics Center
GeneGo MetaCore, MetaBase Procter & Gamble Pharmaceuticals
MetaCore Exelixis, Translational Genomics Research Institute
Genomatix BiblioSphere PathwayEdition National Cancer Institute
InforSense Open Discovery Workflow GlaxoSmithKline
(in partnership with Spotfire), Windber Research Institute
Databases Jubilant Biosys PathArt Solvay Pharmaceuticals, Johns Hopkins Microarray
Core Facility
IT Infrastructure BlueArc 60 TB Titan storage system Genome Sequencing Center at Washington University,
St. Louis.
DataCore Software SANmelody Wellcome Trust Center for Human Genetics
First Genetic Trust enTrust Genetic Alliance BioBank
HP 288-node HP Cluster Platform 3000, 24-node ProLiant cluster, 12 TB StorageWorks Enterprise Virtual Array 5000 Institute of Genomics and Integrative Biology, India
IBM Clinical Genomics Solution University of Utah Health Sciences Center
Western Scientific 16-node 8-way Fusion A8 cluster San Diego Supercomputer Center

Filed under

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.